Anti-obesity medications, including popular GLP-1 drugs like Wegovy, may soon be included in employer-covered health insurance plans, a shift that could significantly expand access to these treatments. As open enrollment…
The Federal Trade Commission (FTC) has launched a major investigation against three of the nation’s largest pharmacy benefit managers (PBMs) for allegedly inflating insulin prices, leaving patients across the U.S.…
As the federal Bridge Access Program nears depletion of its funds, Americans without Medicare, Medicaid, or private insurance may soon face steep costs to receive COVID-19 vaccinations. Health experts are…
In a groundbreaking development, researchers from the University of Texas suggest that the antiviral drug Paxlovid, when administered after a COVID-19 diagnosis, has the potential to save lives and significantly…